Ko Soo Min相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Nonclinical safety evaluation and pharmacokinetics of Ab612, a novel anti-L1CAM (CD171) therapeutic antibody candidate against solid cancer

Ab612（一种新型抗L1CAM (CD171) 治疗性抗体候选药物）的非临床安全性评价和药代动力学研究，该药物可用于治疗实体瘤。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-025-04142-9

Kim, Se-Ho; Chae, Hee Su; Ko, Soo Min; Jeong, Da Som; Lee, Ji-Young; Shin, Young G; Yoon, Seon-Joo; Son, Woo-Chan

发表日期：2025

文献求助收藏

Deep learning-based method for grading histopathological liver fibrosis in rodent models of metabolic dysfunction-associated steatohepatitis.

基于深度学习的代谢功能障碍相关脂肪性肝炎啮齿动物模型肝组织病理学纤维化分级方法

期刊:Frontiers in Medicine

doi:10.3389/fmed.2025.1629036

Ko Soo Min, Shin Jae-Ik, Hong Yiyu, Kim Hyunji, Sohn Insuk, Lee Ji-Young, Han Hyo-Jeong, Jeong Da Som, Lee Yerin, Son Woo-Chan

发表日期：2025

文献求助收藏

Toxicity and efficacy study of a combination of two retinoic acids in an ApoE knockout mouse model of atherosclerosis.

在 ApoE 基因敲除小鼠动脉粥样硬化模型中，对两种维甲酸组合的毒性和疗效进行了研究

期刊:Korean Journal of Physiology & Pharmacology

影响因子:2.2

doi:10.4196/kjpp.24.165

Jeong Da Som, Lee Ji-Young, Han Hyo-Jeong, Ko Soo Min, Lee Dong Hyun, Lee Yerin, Park Young-Sik, Shin Byong-Cheol, Son Woo-Chan

发表日期：2025

文献求助收藏

Tie2 activator 4E2 ameliorates diabetic nephropathy and synergizes with dapagliflozin in a mouse model.

Tie2 激活剂 4E2 可改善糖尿病肾病，并在小鼠模型中与达格列净产生协同作用

期刊:Korean Journal of Physiology & Pharmacology

影响因子:2.2

doi:10.4196/kjpp.24.424

Jeong Da Som, Ko Soo Min, Lee Ji-Young, Han Hyo-Jeong, Lee Yerin, Lee Weon Sup, Lee Eun-Ah, Son Woo-Chan, Shin Jinho

发表日期：2025

文献求助收藏

Comparative Analyses of Inflammatory Response and Tissue Integration of 14 Hyaluronic Acid-Based Fillers in Mini Pigs

14种透明质酸填充剂在小型猪体内的炎症反应和组织整合的比较分析

期刊:Clinical Cosmetic and Investigational Dermatology

影响因子:2.2

doi:10.2147/CCID.S315076

Choi, Min-Seo; Kwak, Seongsung; Kim, Junhyung; Park, Mi-Sun; Ko, Soo Min; Kim, Taehee; Jeong, Da Som; Rhee, Chang-Hoon; Yang, Gi-Hyeok; Son, Woo-Chan; Kang, Won-Ho

发表日期：2021

文献求助收藏